TANNENBAUM RENEE P — SEC Form 4 filings
SEC reporting owner CIK 1543174. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-17 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $34,224 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 3,800 shares, $273,810 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 1,800 shares @ $81.15 ($146,070) in ANI PHARMACEUTICALS INC, filed 2025-12-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | Director | 5 | — | 2 legs · 3,800 sh · $273,810 | 3 |
| Cardiff Oncology, Inc. (CRDF) | Director | 4 | 1 leg · 10,000 sh · $34,224 | — | 3 |
Form 4 filings — TANNENBAUM RENEE P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 40,565 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 4,357 @ $0 | EDGAR |
| 2025-12-09 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 1,800 @ $81.15 | EDGAR |
| 2025-06-30 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 40,565 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 4,336 @ $0 | EDGAR |
| 2024-12-16 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 10,000 @ $3.42 | EDGAR |
| 2024-07-01 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 29,700 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 4,410 @ $0 | EDGAR |
| 2024-05-17 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 2,000 @ $63.87 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1543174 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →